キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/06/20 | 2,418 | 2,444 | 2,402 | 2,416 | +35 | +1.5% | 98,300 |
2022/06/17 | 2,355 | 2,391 | 2,342 | 2,381 | -17 | -0.7% | 132,200 |
2022/06/16 | 2,412 | 2,426 | 2,387 | 2,398 | -2 | -0.1% | 55,900 |
2022/06/15 | 2,436 | 2,451 | 2,394 | 2,400 | -50 | -2% | 75,500 |
2022/06/14 | 2,420 | 2,475 | 2,420 | 2,450 | +1 | ±0% | 101,200 |
2022/06/13 | 2,418 | 2,466 | 2,418 | 2,449 | -11 | -0.4% | 64,900 |
2022/06/10 | 2,520 | 2,520 | 2,453 | 2,460 | -78 | -3.1% | 93,700 |
2022/06/09 | 2,537 | 2,581 | 2,525 | 2,538 | +12 | +0.5% | 110,000 |
2022/06/08 | 2,451 | 2,537 | 2,423 | 2,526 | +37 | +1.5% | 139,500 |
2022/06/07 | 2,511 | 2,515 | 2,482 | 2,489 | -22 | -0.9% | 63,100 |
2022/06/06 | 2,520 | 2,527 | 2,498 | 2,511 | -25 | -1% | 64,600 |
2022/06/03 | 2,530 | 2,559 | 2,520 | 2,536 | +22 | +0.9% | 99,800 |
2022/06/02 | 2,560 | 2,560 | 2,501 | 2,514 | -38 | -1.5% | 79,100 |
2022/06/01 | 2,528 | 2,571 | 2,528 | 2,552 | +30 | +1.2% | 72,300 |
2022/05/31 | 2,599 | 2,599 | 2,507 | 2,522 | -64 | -2.5% | 152,700 |
2022/05/30 | 2,530 | 2,590 | 2,523 | 2,586 | +76 | +3% | 322,300 |
2022/05/27 | 2,530 | 2,530 | 2,475 | 2,510 | +14 | +0.6% | 83,800 |
2022/05/26 | 2,530 | 2,532 | 2,494 | 2,496 | -34 | -1.3% | 62,100 |
2022/05/25 | 2,545 | 2,553 | 2,527 | 2,530 | +1 | ±0% | 75,500 |
2022/05/24 | 2,559 | 2,559 | 2,514 | 2,529 | -55 | -2.1% | 79,900 |
2022/05/23 | 2,552 | 2,591 | 2,544 | 2,584 | +64 | +2.5% | 73,100 |
2022/05/20 | 2,527 | 2,531 | 2,497 | 2,520 | -10 | -0.4% | 79,200 |
2022/05/19 | 2,514 | 2,530 | 2,492 | 2,530 | -52 | -2% | 60,000 |
2022/05/18 | 2,552 | 2,586 | 2,521 | 2,582 | +22 | +0.9% | 79,600 |
2022/05/17 | 2,535 | 2,580 | 2,528 | 2,560 | +42 | +1.7% | 63,600 |
2022/05/16 | 2,622 | 2,624 | 2,504 | 2,518 | -31 | -1.2% | 89,500 |
2022/05/13 | 2,522 | 2,558 | 2,492 | 2,549 | +28 | +1.1% | 116,800 |
2022/05/12 | 2,625 | 2,628 | 2,501 | 2,521 | -94 | -3.6% | 108,700 |
2022/05/11 | 2,597 | 2,655 | 2,560 | 2,615 | +68 | +2.7% | 170,700 |
2022/05/10 | 2,537 | 2,565 | 2,508 | 2,547 | -10 | -0.4% | 48,600 |
2022/05/09 | 2,625 | 2,644 | 2,557 | 2,557 | -68 | -2.6% | 80,400 |
2022/05/06 | 2,599 | 2,639 | 2,582 | 2,625 | +34 | +1.3% | 84,100 |
2022/05/02 | 2,562 | 2,596 | 2,545 | 2,591 | +20 | +0.8% | 76,500 |
2022/04/28 | 2,452 | 2,571 | 2,452 | 2,571 | +128 | +5.2% | 79,200 |
2022/04/27 | 2,494 | 2,529 | 2,423 | 2,443 | -87 | -3.4% | 293,800 |
2022/04/26 | 2,555 | 2,572 | 2,514 | 2,530 | -2 | -0.1% | 90,300 |
2022/04/25 | 2,504 | 2,544 | 2,492 | 2,532 | +28 | +1.1% | 98,900 |
2022/04/22 | 2,446 | 2,504 | 2,445 | 2,504 | +38 | +1.5% | 73,500 |
2022/04/21 | 2,446 | 2,470 | 2,444 | 2,466 | +31 | +1.3% | 91,100 |
2022/04/20 | 2,414 | 2,441 | 2,399 | 2,435 | +35 | +1.5% | 70,100 |
2022/04/19 | 2,400 | 2,426 | 2,395 | 2,400 | -28 | -1.2% | 72,500 |
2022/04/18 | 2,438 | 2,463 | 2,400 | 2,428 | -48 | -1.9% | 53,000 |
2022/04/15 | 2,470 | 2,483 | 2,454 | 2,476 | +4 | +0.2% | 57,700 |
2022/04/14 | 2,455 | 2,476 | 2,446 | 2,472 | +8 | +0.3% | 55,400 |
2022/04/13 | 2,411 | 2,467 | 2,411 | 2,464 | +29 | +1.2% | 67,800 |
2022/04/12 | 2,482 | 2,501 | 2,435 | 2,435 | -70 | -2.8% | 62,200 |
2022/04/11 | 2,485 | 2,505 | 2,468 | 2,505 | +20 | +0.8% | 87,200 |
2022/04/08 | 2,479 | 2,487 | 2,438 | 2,485 | +56 | +2.3% | 151,000 |
2022/04/07 | 2,405 | 2,430 | 2,389 | 2,429 | +6 | +0.2% | 72,100 |
2022/04/06 | 2,445 | 2,486 | 2,417 | 2,423 | -48 | -1.9% | 72,600 |
601~
650
件表示中 / 3589件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 363,000円 | +14.5% | -2.3% | 2.48% | 13.28倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
住友ファーマ | 60,300円 | +7.5% | - | 0.00% | - | 2.10倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 429,000円 | +22.8% | +113.0% | 4.43% | 11.44倍 | 1.05倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ジーエヌアイ | 295,300円 | +52.1% | +23.3% | 0.00% | 20.97倍 | 4.02倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
東和薬品 | 277,000円 | +15.0% | -7.3% | 2.17% | 9.09倍 | 0.86倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム